Still, you'd think one of the big pharmaceutical outfits would step forward.
Why? There's very little to gain and a lot to lose.
I've gotta say I'm a little skeptical of whether or not this is really the funding 'crisis' that the Natural History Museum curators are making it out to be. Let's just say that people trying to raise funds for a cause are the ones most likely to say that their funding prospects are in dire straits (no one's going to donate money to a cause that doesn't need help, right?) The "on our last leg" tactic is used all the time in national labs, museums, etc. to advance the procurement of funding - I smell good old-fashioned politicking here and I'm honestly not terribly worried about this 'incident'. (There are bigger fish to fry in the scientific literacy arena...)